Rachel Deplus
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 15
- Cancer-related gene regulation 8
- RNA modifications and cancer 6
- Genomics and Chromatin Dynamics 4
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 3
- Genetics top 5%
- Genetics and Neurodevelopmental Disorders 2
- Hematology top 5%
- Immunology top 10%
-
- Bone health and treatments 2
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- François FuksYvan de LaunoitCarmen BrennerDavid BernardLuciano Di CroceMario F. FragaLoı̈c BlanchonAleyde Van Eynde
- Partner nations
- BelgiumFranceUnited Kingdom
In The Last Decade
Rachel Deplus
18 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 3.1k
- Cancer Research 522
- Genetics 571
- Hematology 169
- Immunology 268
Countries citing papers authored by Rachel Deplus
This map shows the geographic impact of Rachel Deplus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Deplus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Deplus more than expected).
Fields of papers citing papers by Rachel Deplus
This network shows the impact of papers produced by Rachel Deplus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Deplus. The network helps show where Rachel Deplus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachel Deplus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 10 | |
| 3 | 2021 | 7 | |
| 4 | 2018 | 23 | |
| 5 | 2016 | 9 | |
| 6 | 2016 | 38 | |
| 7 | 2015 | 35 | |
| 8 | 2015 | 48 | |
| 9 | 2014 | 89 | |
| 10 | 2014 | 44 | |
| 11 | 2013 | 387 | |
| 12 | 2012 | 25 | |
| 13 | 2012 | 297 | |
| 14 | 2009 | 72 | |
| 15 | 2008 | 333 | |
| 16 | The Polycomb group protein EZH2 directly controls DNA methylationbreakdown → | 2005 | 1676 |
| 17 | 2004 | 318 | |
| 18 | 2002 | 149 |
About Rachel Deplus
Rachel Deplus is a scholar working on Molecular Biology, Cancer Research, Clinical Biochemistry, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 3.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (15 papers), Cancer-related gene regulation (8 papers), RNA modifications and cancer (6 papers), Genomics and Chromatin Dynamics (4 papers), Cancer-related molecular mechanisms research (3 papers), Bone health and treatments (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). The work is most often cited by research in Molecular Biology (3.1k citations), Cancer Research (522 citations), Genetics (571 citations), Hematology (169 citations) and Immunology (268 citations). Rachel Deplus has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include François Fuks, Yvan de Launoit, Carmen Brenner, David Bernard, Luciano Di Croce, Mario F. Fraga, Loı̈c Blanchon, Aleyde Van Eynde, Mathieu Bollen and Manel Esteller. Their work appears in journals such as The EMBO Journal, Oncotarget, Nucleic Acids Research, Molecular and Cellular Biology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.